PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced the signing of a new Research Collaboration Agreement (RCA) with the National Cancer Centre of Singapore (NCCS). This collaboration aims to accelerate cancer research by leveraging PacBio’s advanced sequencing technologies, including the innovative Onso short-read sequencing platform, to profile the genomic landscape …
PacBio enters new collaboration with the National Cancer Centre of Singapore – will emphasize single-cell RNA sequencing
Share.